Alcon Share Holder Equity 2019-2025 | ALC
Alcon share holder equity from 2019 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Alcon share holder equity for the quarter ending September 30, 2025 was $22.088B, a 3.27% increase year-over-year.
- Alcon share holder equity for 2024 was $21.553B, a 4.5% increase from 2023.
- Alcon share holder equity for 2023 was $20.624B, a 4.81% increase from 2022.
- Alcon share holder equity for 2022 was $19.677B, a 2.19% increase from 2021.
|
Alcon Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $21,553 |
| 2023 | $20,624 |
| 2022 | $19,677 |
| 2021 | $19,256 |
| 2020 | $18,822 |
| 2019 | $19,303 |
| 2018 | $22,639 |
|
Alcon Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $22,088 |
| 2025-06-30 | $22,130 |
| 2025-03-31 | $22,019 |
| 2024-12-31 | $21,553 |
| 2024-09-30 | $21,389 |
| 2024-06-30 | $20,941 |
| 2024-03-31 | $20,827 |
| 2023-12-31 | $20,624 |
| 2023-09-30 | $20,152 |
| 2023-06-30 | $19,939 |
| 2023-03-31 | $19,864 |
| 2022-12-31 | $19,677 |
| 2022-09-30 | $19,647 |
| 2022-06-30 | $19,541 |
| 2022-03-31 | $19,486 |
| 2021-12-31 | $19,256 |
| 2021-09-30 | $19,093 |
| 2021-06-30 | $19,064 |
| 2021-03-31 | $18,913 |
| 2020-12-31 | $18,822 |
| 2020-09-30 | $18,656 |
| 2020-06-30 | $18,773 |
| 2020-03-31 | $19,171 |
| 2019-12-31 | $19,303 |
| 2019-09-30 | $19,385 |
| 2019-06-30 | $19,452 |
| 2019-03-31 | $0 |
| 2018-12-31 | |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $40.074B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $240.247B | 28.55 |
| Intuitive Surgical (ISRG) | United States | $188.491B | 72.03 |
| IDEXX Laboratories (IDXX) | United States | $55.181B | 54.80 |
| Edwards Lifesciences (EW) | United States | $49.001B | 32.86 |
| IQVIA Holdings (IQV) | United States | $40.710B | 22.70 |
| Mettler-Toledo (MTD) | United States | $29.378B | 34.37 |
| DexCom (DXCM) | United States | $28.830B | 39.74 |
| STERIS (STE) | Ireland | $25.607B | 26.43 |
| Waters (WAT) | United States | $23.844B | 31.53 |
| Coloplast (CLPBY) | Denmark | $19.494B | 33.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.744B | 0.00 |
| Hologic (HOLX) | United States | $16.742B | 17.59 |
| Penumbra (PEN) | United States | $14.041B | 98.77 |
| Globus Medical (GMED) | United States | $12.667B | 26.58 |
| Masimo (MASI) | United States | $7.731B | 24.77 |
| Glaukos (GKOS) | United States | $7.231B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.112B | 19.42 |
| TransMedics (TMDX) | United States | $4.719B | 55.91 |
| Teleflex (TFX) | United States | $4.644B | 7.40 |
| LivaNova (LIVN) | United Kingdom | $3.488B | 18.84 |
| Veracyte (VCYT) | United States | $3.462B | 39.46 |
| Integer Holdings (ITGR) | United States | $2.997B | 14.07 |
| Elekta AB (EKTAY) | Sweden | $2.473B | 23.14 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| Artivion (AORT) | United States | $2.081B | 95.48 |
| UFP Technologies (UFPT) | United States | $2.057B | 27.15 |
| Nihon Kohden (NHNKY) | Japan | $2.028B | 17.70 |
| PROCEPT BioRobotics (PRCT) | United States | $1.717B | 0.00 |
| AxoGen (AXGN) | United States | $1.476B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.396B | 0.00 |
| IRadimed (IRMD) | United States | $1.322B | 62.96 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.986B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.950B | 5.14 |
| Pacific Biosciences Of California (PACB) | United States | $0.806B | 0.00 |
| SiBone (SIBN) | United States | $0.734B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.727B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.667B | 38.78 |
| Alpha Tau Medical (DRTS) | Israel | $0.608B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.608B | 12.13 |
| NeuroPace (NPCE) | United States | $0.568B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.477B | 13.18 |
| OrthoPediatrics (KIDS) | United States | $0.464B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.438B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.388B | 64.59 |
| Sight Sciences (SGHT) | United States | $0.339B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Anteris Technologies Global (AVR) | Australia | $0.271B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.270B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.203B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.195B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Neuronetics (STIM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.135B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.133B | 0.00 |
| Solana (HSDT) | United States | $0.133B | 0.00 |
| Hyperfine (HYPR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.094B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.085B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.74 |